Frontlight ResearchEarly access
Trial site
Neurology Offices of South Florida
- 6running trials
- 4closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Migraine2 trials
- Multiple sclerosis2 trials
- Frontotemporal dementia1 trial
- Myasthenia gravis1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Terminated2 trials
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company3 trials
- Cassava Sciences, Inc.2 trials
- Pfizer2 trials
- Amgen1 trial
- argenx1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Migraine1 recruiting
Closed trials
Terminated
Open-label Extension for Phase 3 Clinical Trials of Simufilam
Completed
Completed
Terminated
A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
Site data: ClinicalTrials.govUpdated 17 Nov 2026